Home › Funds › Arax Advisory Partners › MRK

Arax Advisory Partners position in MRK

MERCK & CO · Health Care

Arax Advisory Partners reported holding 876,253 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$127.3M, representing 0.81% of its reported portfolio and ranking #15 among its reported holdings. Arax Advisory Partners has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)876.25K sh
Reported value held$127.33M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arax Advisory Partners's MRK position evolved

Arax Advisory Partners first disclosed a stake in MRK in Q3 2023 at 4,956 shares (US$510K). The position peaked in Q3 2026 at 876,253 shares, worth US$127.3M. Across 13 filings, Arax Advisory Partners increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 876,253 shares valued at US$127.3M — an increase of 267,645 shares quarter over quarter.. Notable position changes include a 86% increase in Q1 2025 (shares fell 11% over the following quarter), a 2209% increase in Q2 2025 (shares rose 7% over the following quarter), a 100% increase in Q2 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.96K $510.25K New
Q4 2023 5.04K $549.19K Add
Q1 2024 5.26K $694.38K Add
Q2 2024 6.15K $761.18K Add
Q3 2024 6.41K $727.31K Add
Q4 2024 6.58K $655.07K Add
Q1 2025 12.26K $1.10M Add
Q2 2025 283.14K $22.41M Add
Q3 2025 429.29K $36.03M Add
Q4 2025 293.93K $30.94M Reduce
Q1 2026 303.86K $36.52M Add
Q2 2026 608.61K $78.21M Add
Q3 2026 876.25K $127.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has Arax Advisory Partners held MRK?

Arax Advisory Partners has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Arax Advisory Partners's current position in MRK?

As of Q3 2026, Arax Advisory Partners holds 876.25K shares of MRK (MERCK & CO), valued at $127.33M, representing 0.81% of its reported portfolio and ranking #15.

Has Arax Advisory Partners been buying or selling MRK?

In the latest 13F filing (Q3 2026), Arax Advisory Partners increased its position in MRK. The position peaked in Q3 2026 at 876.25K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.